Brief: Yichang Hec Changjiang Pharmaceutical Says Proposed Privatisation Of Co
May 10 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
1558.HK :
* PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC
CHANGJIANG
PHARMACEUTICAL BY SUNSHINE LAKE PHARMA
* PROPOSED PRE-CONDITIONAL PRIVATISATION OF YICHANG HEC
CHANGJIANG
PHARMACEUTICAL BY WAY OF MERGER
* VALUE ESTIMATED BY VALUATION ADVISER AS AT 8 MARCH 2024 OF
HK$73.21 PER OFFEROR H SHARE IN MERGER
* COMPANY WILL PAY A SPECIAL DIVIDEND TO SHAREHOLDERS
* APPLICATION HAS BEEN MADE FOR RESUMPTION OF TRADING IN H
SHARES
FROM 13 MAY
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million